Cargando…

P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Detalles Bibliográficos
Autores principales: Boss, Isaac, Thompson, Ethan, Gaudy, Allison, Vu, Thi Minh Diem, Godwin, Colin, Burgess, Michael, Wong, Sandy W., Costa, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430572/
http://dx.doi.org/10.1097/01.HS9.0000970204.77796.ce
_version_ 1785090997092352000
author Boss, Isaac
Thompson, Ethan
Gaudy, Allison
Vu, Thi Minh Diem
Godwin, Colin
Burgess, Michael
Wong, Sandy W.
Costa, Luciano
author_facet Boss, Isaac
Thompson, Ethan
Gaudy, Allison
Vu, Thi Minh Diem
Godwin, Colin
Burgess, Michael
Wong, Sandy W.
Costa, Luciano
author_sort Boss, Isaac
collection PubMed
description
format Online
Article
Text
id pubmed-10430572
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305722023-08-17 P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) Boss, Isaac Thompson, Ethan Gaudy, Allison Vu, Thi Minh Diem Godwin, Colin Burgess, Michael Wong, Sandy W. Costa, Luciano Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430572/ http://dx.doi.org/10.1097/01.HS9.0000970204.77796.ce Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Boss, Isaac
Thompson, Ethan
Gaudy, Allison
Vu, Thi Minh Diem
Godwin, Colin
Burgess, Michael
Wong, Sandy W.
Costa, Luciano
P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_fullStr P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full_unstemmed P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_short P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_sort p825: soluble factors correlated with cytokine release syndrome (crs) with iv vs subcutaneous (sc) alnuctamab (alnuc; bms-986349; cc-93269) in patients with relapsed/refractory multiple myeloma (rrmm)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430572/
http://dx.doi.org/10.1097/01.HS9.0000970204.77796.ce
work_keys_str_mv AT bossisaac p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT thompsonethan p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT gaudyallison p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT vuthiminhdiem p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT godwincolin p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT burgessmichael p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT wongsandyw p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm
AT costaluciano p825solublefactorscorrelatedwithcytokinereleasesyndromecrswithivvssubcutaneousscalnuctamabalnucbms986349cc93269inpatientswithrelapsedrefractorymultiplemyelomarrmm